Propylamine

Propylamine

SCHEMBL4175347

CCCN.CCCNC(=O)O

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 1/20 0.43
MMP2 P08253 1/20 0.43
MMP3 P08254 1/20 0.43
MMP9 P14780 1/20 0.43
KDM4C Q9H3R0 1/20 0.42
EPHX1 P07099 2/20 0.41
MCL1 Q07820 1/20 0.40
ALOX15 P16050 1/20 0.38
DPP7 Q9UHL4 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C19 P33261 1/20 0.37
CTSD P07339 1/20 0.37
PAOX Q6QHF9 3/20 0.37
POLB P06746 1/20 0.36
RRM1 P23921 1/20 0.36
KDM4E B2RXH2 3/20 0.35
ALDH1A1 P00352 1/20 0.35
KMT2A Q03164 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL43354 0.89
SCHEMBL29032808 0.89 PAOX (0.52) EPHX1ALOX15PAOXALDH1A1KMT2A
Hydrochloric Acid SCHEMBL11072255 0.87
SCHEMBL27787563 0.87
Propane SCHEMBL31494775 0.87 MMP1 (0.48) MMP1MMP2MMP3MMP9KDM4C
SCHEMBL28156347 0.87
SCHEMBL27787561 0.87 MMP1 (0.48) MMP1MMP2MMP3MMP9KDM4C
Acetic Acid SCHEMBL10885571 0.84 MMP1 (0.46) MMP1MMP2MMP3MMP9KDM4C
Iodomethane SCHEMBL28143094 0.84
Propylamine SCHEMBL28079902 0.82 EPHX1 (0.59) EPHX1DPP7PAOXRRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10799443-B2 Crosslinkable coating compositions formulated with dormant carbamate initiator ELEMENTIS SPECIALTIES, INC. (US) 2020-10-13 US claimed
US-20200214966-A1 CROSSLINKABLE COATING COMPOSITIONS FORMULATED WITH DORMANT CARBAMATE INITIATOR ELEMENTIS SPECIALTIES, INC. (US) 2020-07-09 US claimed
EP-1846422-B1 ORGANIC SILVER COMPLEXES, THEIR PREPARATION METHODS AND THEIR METHODS FOR FORMING THIN LAYERS INKTEC CO LTD (KR) 2016-04-13 EP claimed
US-12623999-B2 Carbamate production method, carbamate ester production method, and urea derivative production method NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2026-05-12 US disclosed
EP-4288155-A1 CROSSLINKABLE COATING COMPOSITIONS Elementis Specialties, Inc. (US) 2023-12-13 EP disclosed
EP-3824893-B1 CROSSLINKABLE COATING COMPOSITIONS FORMULATED WITH DORMANT CARBAMATE INITIATOR ELEMENTIS SPECIALTIES INC (US) 2023-11-01 EP disclosed
US-11801214-B2 Crosslinkable coating compositions formulated with dormant carbamate initiator ELEMENTIS SPECIALTIES, INC. (US) 2023-10-31 US disclosed
US-20230212110-A1 CARBAMATE PRODUCTION METHOD, CARBAMATE ESTER PRODUCTION METHOD, AND UREA DERIVATIVE PRODUCTION METHOD NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2023-07-06 US disclosed
EP-4169901-A1 CARBAMATE PRODUCTION METHOD, CARBAMATE ESTER PRODUCTION METHOD, AND UREA DERIVATIVE PRODUCTION METHOD National Institute Of Advanced Industrial Science and Technology (JP) 2023-04-26 EP disclosed
CN-115956067-A Method for producing carbamate, and method for producing urea derivative 国立研究开发法人产业技术总合研究所 2023-04-11 CN disclosed
EP-3638417-B1 COATING SYSTEM ELEMENTIS SPECIALTIES INC (US) 2022-10-12 EP disclosed
WO-2006083153-A1 ORGANIC SILVER COMPLEXES, THEIR PREPARATION METHODS AND THEIR METHODS FOR FORMING THIN LAYERS INKTEC CO., LTD. (KR) 2006-08-10 WO disclosed
EP-0992497-B1 Manufactoring process for 1,3-Dialkyl-2-imidazolinones MITSUI CHEMICALS INC (JP) 2003-12-17 EP disclosed
US-6492528-B1 1,3-DIALKYL-2-IMIDAZOLIDINONES IN A DIRECT ONE-STEP REACTION FROM INDUSTRIALLY AVAILABLE ALKYLENE CARBONATE, N-ALKYLETHANOLAMINE OR 1,2-DIOL, WHICH CAN MINIMIZE FORMING SOLID MATERIALS AND BE READILY CONDUCTED IN AN INDUSTRIAL MITSUI CHEMICALS, INC. (JP) 2002-12-10 US disclosed
EP-1148052-A2 1,3-dialkyl-2-imidazolidinones and a manufacturing process therefor Mitsui Chemicals, Inc. (JP) 2001-10-24 EP disclosed
EP-1148051-A2 1,3-dialkyl-2-imidazolidinones and a manufacturing process therefor Mitsui Chemicals, Inc. (JP) 2001-10-24 EP disclosed
EP-0992497-A1 1,3-Dialkyl-2-imidazolidinones and a manufacturing process therefor Mitsui Chemicals, Inc. (JP) 2000-04-12 EP disclosed
EP-0114399-B1 PROCESS FOR PREPARING SILYL CARBAMATES UNION CARBIDE CORPORATION (US) 1986-09-17 EP disclosed
US-4496754-A Silyl carbamates and synthesis thereof UNION CARBIDE CORPORATION (US) 1985-01-29 US disclosed
EP-0114399-A1 Process for preparing silyl carbamates UNION CARBIDE CORPORATION (US) 1984-08-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200214966-A1 CROSSLINKABLE COATING COMPOSITIONS FORMULATED WITH DORMANT CARBAMATE INITIATOR ETF1, CECR2, H1-2 MMP1 2555/4885MMP2 3950/4885MMP3 4185/4885
US-11801214-B2 Crosslinkable coating compositions formulated with dormant carbamate initiator ETF1, CECR2, H1-2 MMP1 2555/4885MMP2 3950/4885MMP3 4185/4885
US-10799443-B2 Crosslinkable coating compositions formulated with dormant carbamate initiator ETF1, CECR2, H1-2 MMP1 2555/4885MMP2 3950/4885MMP3 4185/4885
US-12623999-B2 Carbamate production method, carbamate ester production method, and urea derivative production method CPS1, CA2, CHRM2 MMP1 3286/4885MMP2 3155/4885MMP3 4341/4885
US-20230212110-A1 CARBAMATE PRODUCTION METHOD, CARBAMATE ESTER PRODUCTION METHOD, AND UREA DERIVATIVE PRODUCTION METHOD CPS1, ATM, OAT MMP1 3353/4885MMP2 2717/4885MMP3 3815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.